A Hybrid AI Biopharma Platform

BioCyto Labs combines artificial intelligence, computational formulation science, systems biology, and translational nanoparticle engineering to support the development of advanced CNS therapeutic delivery systems.
The company operates through an integrated dry-lab and targeted wet-lab model enabling rapid iteration between:
 
  • AI-guided discovery
  • Computational optimisation
  • Experimental prototyping
  • Translational refinement
BioCyto’s scientific focus includes:

  • Neuroinflammation
  • Brain and spinal cord tumours
  • Targeted CNS delivery
  • RNA therapeutics
  • Precision nanomedicine